According to Botanix Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 524.924.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 6.54 | -41.15% |
2023-12-31 | 11.1 | 45.83% |
2022-12-31 | 7.62 | 200.67% |
2021-12-31 | 2.53 | -55.81% |
2020-12-31 | 5.73 | -95.56% |
2019-12-31 | 129 | 4071.57% |
2018-12-31 | 3.10 | -53.79% |
2017-12-31 | 6.70 | 22.51% |
2016-12-31 | 5.47 | 359.22% |
2015-12-31 | 1.19 | 138.98% |
2014-12-31 | 0.4986 | -159.28% |
2013-12-31 | -0.8412 | 44.14% |
2012-12-31 | -0.5836 | 71.19% |
2011-12-31 | -0.3409 | -87.65% |
2010-12-31 | -2.76 | -114.59% |
2009-12-31 | 18.9 | 94.77% |
2008-12-31 | 9.71 | -8.49% |
2007-12-31 | 10.6 | 72.21% |
2006-12-31 | 6.16 | -22.09% |
2005-12-31 | 7.91 | -61.04% |
2004-12-31 | 20.3 | 2502.87% |
2003-12-31 | 0.7800 | -26.33% |
2002-12-31 | 1.06 |